TREA

79211373 - ANEMOCYTE

Follow

Information

  • Trademark
  • 79211373
  • Serial Number
    79211373
  • Registration Number
    5440621
  • Filing Date
    February 06, 2017
    7 years ago
  • Registration Date
    April 10, 2018
    6 years ago
  • Transaction Date
    December 16, 2024
    11 days ago
  • Status Date
    April 10, 2018
    6 years ago
  • Published for Opposition Date
    January 23, 2018
    6 years ago
  • Location Date
    December 16, 2024
    11 days ago
Information
Mark Drawing Code
5
Mark Identification
ANEMOCYTE
Case File Statements
  • DM0000: The mark consists of the following: the stylized term "ANEMOCYTE" with the letters "ANEM" and "YTE" appearing in dark grey, and the letters "OC" merged and appearing in light blue, green, blue and light grey.
  • GS0051: Pharmaceutical [ and veterinary ] preparations, namely, [ recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues ] for use in human [ and veterinary ] medicine; chemical preparations for pharmaceutical or medical purposes, namely, [ recombinant therapeutic proteins, ] nucleic acids, [ peptides, cells, genes and tissues ] for the treatment of disorders in the field of cancer, immunology, [ heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco skeletal, metabolic diseases, dermatology; prescription and non-prescription ] medicines, namely, [ pills, tablets, capsules, caplets, liquid drops, sachets, syringes, infusion bags, ] vials and pharmaceutical preparations for the treatment of disorders in the field of cancer, immunology [ , heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology ] ; biological preparations for the treatment of disorders in the field of cancer, immunology [ , heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology ] ; biological preparations for medical and pharmaceutical use for the treatment of disorders in the field of cancer, immunology, [ heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; chemical preparations for pharmaceutical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical and veterinary purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use, namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes ] ; biological reagents for medical use; medicinal products based on cells and genes, namely, [ somatic cells, ] genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical [ and veterinary ] purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes; [ biological reagents for medical use; medicinal products based on cells and genes, namely, somatic cells, genetically modified cells, viral vectors, nucleic acids and engineered tissues; products for somatic cell therapy, namely, adult stem cells, t-cells, b-cells, nk cells, dendritic cells, monocytes, macrophages, adipocytes, keratinocytes, erythrocytes, platelets, ] products for gene therapy, namely, [ genetically modified cells, viral vectors, ] nucleic acids; [ tissue engineered products, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace or restore a lost or impaired tissue or function; ] products for regenerative medicine, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace, restore or promote the repair, replacement or regeneration of a lost or impaired tissue or function; products for personalized medicine made of [ autologous cells or proteins or ] nucleid acids derived from individual genomic sequences; [ preparations made up of cells for medical or clinical use; ] preparations made up of nucleic acids, namely, nucleic acid sequences and chemical reagents for medical purposes [ ; preparations made up of tissues, namely, biological tissue cultures for medical purposes; vaccines; recombinant proteins supplements; therapeutic kits consisting of therapeutic antibodies, buffers, and reagents for use in disease treatment and therapy ]
  • CC0000: The color(s) light blue, green, blue, light grey and dark grey is/are claimed as a feature of the mark.
  • GS0421: Services of laboratory analysis and industrial research in the medical and pharmaceutical fields; research and development in the pharmaceutical and biotechnology fields; research and development in the field of micro-organisms and cells; research and development in biochemistry; scientific research and development in biology; research and development in the field of diagnostic preparations; services of medical laboratories; medical information and data on research and development in the medical and veterinary fields; scientific and technological services, namely, scientific research and, literature scientific research in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology, consultancy to ensure compliance with quality standards, the design and validation of manufacturing processes
Case File Event Statements
  • 7/6/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/8/2017 - 7 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/7/2017 - 7 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 12/11/2017 - 7 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/8/2017 - 7 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/11/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/12/2017 - 7 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/12/2017 - 7 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/18/2017 - 7 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/18/2017 - 7 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/4/2017 - 7 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/20/2017 - 7 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/20/2017 - 7 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/3/2018 - 6 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/3/2018 - 6 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/22/2018 - 6 years ago
    23 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 12/11/2017 - 7 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/11/2017 - 7 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/11/2017 - 7 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/3/2018 - 6 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/23/2018 - 6 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/23/2018 - 6 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/10/2018 - 6 years ago
    22 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/10/2018 - 6 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/10/2018 - 6 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/11/2018 - 6 years ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINV
  • 10/24/2022 - 2 years ago
    36 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/16/2018 - 6 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/16/2018 - 6 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/9/2021 - 3 years ago
    29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/24/2022 - 2 years ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/24/2022 - 2 years ago
    33 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 10/24/2022 - 2 years ago
    35 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/24/2022 - 2 years ago
    30 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/24/2022 - 2 years ago
    34 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/24/2022 - 2 years ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/10/2023 - a year ago
    37 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 4/9/2024 - 8 months ago
    38 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 12/16/2024 - 11 days ago
    40 - POST REGISTRATION ACTION MAILED - SEC. 71 & 15 Type: PR75
  • 11/20/2024 - a month ago
    39 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE